This is the Drug Review Briefing Session presentation material held on 10-Nov-2023. MSDF published these slides to help the pharmaceutical industry improve their understanding of drug review and develop safe and effective drugs.
It covered the following contents:
- Introduction of the New Standard for Nitrosamine Impurities for Global Regulatory Harmonization
- Main causes and changes in the environment of nitrosamine occurrence
- Method for setting impurity standards
- New impurity standard setting method: CPCA
Google translation of presentation ppt
Original Korean document
IDRAC_375151_12-Dec-2023_MFDS Presentation_ Pharmaceutical Products Drug Review Briefing Session in .pdf (3.6 MB)